Results 131 to 140 of about 8,263 (168)

Ionizing radiation expands a p90RSK-activated patrolling monocyte subset: modulation by colchicine. [PDF]

Front Cardiovasc Med
Imanishi M, Samanthapudi VSK, Le NT, Rivera LA, Kim JH, Lee J, Mejia GF, Hoang O, Deswal A, Schadler KL, Hildebrandt MAT, Yusuf SW, Wang G, Burks JK, Nurieva RI, Palaskas NL, Nead KT, Amir ED, Koutroumpakis E, Lin SH, Abe JI, Kotla S.   +21 more
europepmc   +1 more source

Single-cell CyTOF profiling reveals alterations in B, T and macrophage subsets during murine hepatic aging. [PDF]

Front Immunol
Ding Z, Fang B, Peng J, Wang S, Tian X, Chen G, Wei Y, Gao Y, Li Y, Sun J.   +9 more
europepmc   +1 more source

<i>In vitro</i> generated macrophages reflect the immunosuppressive phenotype of <i>in vivo</i> glioblastoma-associated macrophages. [PDF]

Oncoimmunology
Nazzaro M, Mardis ER, Artomov M, Juenger E, Lyberger J, Damante M, Behbehani G, Sarkar S, Rajappa P.   +8 more
europepmc   +1 more source

Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial. [PDF]

Cell Rep Med
Ager CR, Obradovic A, McCann P, Chaimowitz M, Wang ALE, Shaikh N, Shah P, Pan SS, Laplaca CJ, Virk RK, Hill JC, Jugler C, DeFranco G, Bhattacharya N, Copple KR, Nguyen P, Scher HI, DeCastro GJ, Anderson CB, McKiernan JM, Spina CS, Stein MN, Runcie K, Drake CG, Califano A, Dallos MC.   +25 more
europepmc   +1 more source

Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer. [PDF]

Cancer Immunol Res
Zhang Y, Kadiyala P, Yan W, Brown K, Avritt FR, Donahue KL, Procario MC, Okoye JO, Giridharan T, Elhossiny AM, Espinoza CE, Awad D, Lasse Opsahl EL, Medina-Cabrera PI, Velez-Delgado A, Menjivar RE, Yang OA, Yang S, He X, Gupta S, Tariq R, Brandt AR, Wang X, denDekker A, Nwosu ZC, Carpenter ES, Courtney AH, Bednar F, Frankel TL, Lyssiotis CA, Zheng B, Kryczek I, Pasca di Magliano M.   +32 more
europepmc   +1 more source

Rheumatoid arthritis developing after mogamulizumab treatment in Sézary syndrome. [PDF]

EULAR Rheumatol Open
Nishimura N, Shirakashi M, Kiyohara E, Morinobu A, Murakami K.   +4 more
europepmc   +1 more source

Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial. [PDF]

Clin Cancer Res
Li Z, Izadmehr S, Hoffman-Censits J, Maughan B, Mayer T, Tan A, Brody R, Xie H, Nie K, Kelly G, Ioannou G, Cabal R, Tuballes K, Guo R, Figueiredo I, Del Valle DM, Mehrazin R, Yu M, Zhao Q, Kim-Schulze S, Sfakianos JP, Gupta S, Hahn NM, Gonzalez-Kozlova E, Gnjatic S, Galsky MD.   +25 more
europepmc   +1 more source

Spatial multiomics reveals irreversible electroporation-induced immuno-metabolic characteristics of the inflammatory margin in liver cancer. [PDF]

Commun Biol
Liu J, Guan S, Sun Z, Shi X, Tian G, Pan J, Zhao X, Jiang T.   +7 more
europepmc   +1 more source

CyTOF® for the Masses

Frontiers in Immunology, 2022
Mass cytometry has revolutionized immunophenotyping, particularly in exploratory settings where simultaneous breadth and depth of characterization of immune populations is needed with limited samples such as in preclinical and clinical tumor immunotherapy.
Asha Pillai, Anouk A J Hamers, Iyer Akshay   +2 more
exaly   +4 more sources

Applications of CyTOF in Brain Immune Component Studies

Engineering, 2022
Abstract The brain is the most heterogeneous and complex tissue in the body. Previous studies have shown that immune cells are essential functional components in both healthy and pathological brains. Cytometry by the time of flight (CyTOF) is a high-dimensional single-cell detection technology that allows measurements of up to 100 cell markers with a
Baohui Xu, Lixiang Xue
exaly   +2 more sources